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Summary 
Delivery of effector molecules into LMmev macrophages by enteropathogenic E.coli (EPEC), via its 
Type Three Secretion System (T3SS), inhibits bacterial uptake by a phosphatidylinositol-3 (PI-3) 
kinase-dependent pathway. The T3SS system, encoded by the LEE (Locus of enterocyte effacement) 
pathogenicity island, delivers LEE and non-LEE-encoded effector proteins into host cells. Previous 
studies discounted essential roles for the LEE-encoded Map, EspF, Tir  or Intimin proteins in this 
process but correlated it with loss of phosphorylation of the PI-3 kinase substrate, Akt (Celli et al., 
2001 EMBO J). Given the more recent finding that these bacterial proteins are multifunctional and can 
act together to subvert host cellular processes we generated a quadruple deletion mutant (Map, Tir, 
EspF and Intimin deficient) to unearth any cooperativity in inhibiting uptake. The quadruple mutant 
was as defective as the T3SS-defective strain at preventing bacterial uptake with further studies 
revealing a surprising dependence on EspF but not Map, Tir or Intimin. Subversive activities 
previously associated with EspF are disruption of epithelial barrier function and programmed cell 
death, with the latter linked to EspF targeting mitochondria. Interestingly, the C-terminal domain 
possesses a polyproline motif associated with protein-protein interactions. We demonstrate that EspF-
mediated inhibition of PI-3 kinase-dependent uptake is i) independent of mitochondrial targeting ii) 
requires the N-terminal domain with iii) the C-terminal domain sufficient to disrupt barrier function 
but not inhibition of bacterial uptake. Moreover, loss of PI-3 kinase-dependent phosphorylation of Akt 
and gross changes in host phosphotyrosine protein profiles could not be linked to inhibition of the PI-3 
kinase-dependent uptake process. 
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Introduction 
The ability of enteropathogenic E.coli (EPEC) to cause enteric disease is dependent on the LEE 
pathogenicity island that encodes proteins involved in the regulation and expression of a Type Three 
Secretion System (T3SS) as well as substrates for secretion (Dean et al., 2005; Nataro and Kaper, 
1998). The multiprotein T3SS spans the bacterial double membrane envelope to transfer three EPEC 
secreted proteins (EspA, EspB and EspD) out of the cell. EspA polymerises to form a filamentous 
extension of the T3SS, while EspB and EspD are delivered into the plasma membrane, in a T3SS-
dependent manner, to form a pore-like structure enabling bacterial ‘effector’ proteins to be injected 
directly into the target cell through the contiguous T3SS-Esp ‘translocon’. While the LEE is reported 
to encode only six effector molecules (Tir, Map, EspF, EspG, EspH and SepZ), additional effectors 
are encoded outside the LEE that depend on the T3SS for secretion (Dean et al., 2005; Kanack et al., 
2005). 
Whilst little is currently known about the function of the non-LEE-encoded effectors, recent 
studies have revealed the multifunctional and cooperative nature of LEE effectors (Dean et al., 2005). 
Thus, the Translocated intimin receptor (Tir) is inserted into the host plasma membrane where it acts 
as a receptor for the LEE-encoded bacterial outer membrane protein, Intimin, to establish intimate 
contact between bacteria and host cells (Kenny et al., 1997). Tir is the only effector molecule reported 
to be essential for virulence with all known functions dependent on its interaction with Intimin – 
another essential virulence determinant (Deng et al., 2003; Marches et al., 2000). Intimin interaction 
with Tir triggers several responses within host cells including i) recruitment of the host actin 
nucleating machinery to form pedestal-like structures beneath the adherent bacteria (Campellone and 
Leong, 2003) ii) tyrosine phosphorylation of PLC-γ1 (Kenny and Finlay, 1997), iii) Cdc42-dependent 
uptake of EPEC into non-phagocytic cell types (Jepson et al., 2003) and iv) down-regulation of EPEC-
induced actin-rich filopodia (Kenny et al., 2002). Another two LEE effector molecules, EspF and 
Map, target mitochondria where they interfere with organelle membrane potential which can trigger 
cell death (Nagai et al., 2005; Nougayrede and Donnenberg, 2004; Kenny and Jepson, 2000). Both 
molecules also act together to disrupt epithelial barrier function though this Map activity does not 
require targeting to mitochondria (Dean and Kenny, 2004; McNamara et al., 2001). Intriguingly, the 
barrier disrupting activity of these molecules in polarised Caco-2 cells depends on the bacteria 
expressing Intimin, but not its receptor Tir, implying that these activities require signalling mediated 
by Intimin interaction with non-Tir receptor(s) (Dean et al., 2005; Dean and Kenny, 2004). Map also 
triggers Cdc42-dependent formation of actin-rich filopodia at the site of infection in a manner 
independent of mitochondrial targeting (Kenny et al., 2002). This Map-mediated function inhibits 
Intimin/Tir-triggered pedestal formation providing a possible explanation of why Tir-Intimin 
signalling down-regulates this function (Kenny et al., 2002). In contrast to this antagonistic 
relationship, a Tir (in a Intimin-dependent manner) and Map activity both induce Cdc42-dependent 
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signalling that internalises EPEC into non-phagocytic cells, with these signalling activities acting 
synergistically to increase bacterial uptake (Jepson et al., 2003). EspF carries a C-terminal polyproline 
region indicative of a role in protein-protein interactions (Dean and Kenny, 2004; McNamara et al., 
2001) and, like Tir (Batchelor et al., 2004), reportedly interacts with the intermediate filament (IF) 
protein, cytokeratin 18 (Viswanathan et al., 2004). Relatively little is known about EspH or EspZ 
(Kanack et al., 2005; Tu et al., 2003), though EspG functions along with its non-LEE encoded 
homologue, Orf3, to disrupt the host microtubule network (Matsuzawa et al., 2004). More recently, 
both of these molecules have been shown to be able to influence EPEC’s ability to compromise 
epithelial barrier function (Tomson et al., 2005). While Intimin is not considered a classic effector 
molecule, as it is apparently not delivered into host cells, it can transduce signals into the host cell via 
its interaction with Tir and other non-Tir receptors (Dean and Kenny, 2004; Sinclair and O'Brien, 
2001; Phillips et al., 2000; Frankel et al., 1996). 
EPEC interaction with host cells triggers the T3SS-dependent dephosphorylation of a large 
number of host phosphotyrosine proteins (Kenny and Finlay, 1997) with this process linked to EPEC’s 
ability to inhibit it uptake into professional phagocytes by a phosphatidylinositol-3 (PI-3) kinase-
dependent mechanism (Celli et al., 2001; Goosney et al., 1999). Moreover, this latter process is 
reportedly independent of the Tir, Intimin, EspF or Map proteins (Kenny and Jepson, 2000) though it 
has been correlated with loss of phosphorylation of the PI-3 kinase substrate, Akt (Celli et al., 2001). 
Given our findings that Map, EspF, Tir and Intimin are multifunctional and can act together in 
redundant, synergistic and antagonistic relationships (Dean et al., 2005), this prompted us to test 
whether these proteins cooperate to inhibit uptake. Studies with a quadruple mutant (deficient for 
Map, EspF, Tir and Intimin) confirmed this hypothesis with further investigations revealing a role for 
only EspF in inhibiting PI-3 kinase-dependent uptake into J774.A1 macrophages. Additional studies 
define EspF features that are either essential or non-essential for this inhibitory activity as well as 
probing reported relationship between host responses and inhibition of bacterial uptake.  
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Results 
T3SS-dependent inhibition of EPEC uptake into J774.A1 macrophages is dependent on LEE-
encoded effector molecules  
To test the hypothesis that the Intimin, Tir, Map and EspF molecules may function together to inhibit 
EPEC internalisation into phagocytic cells, we generated a quadruple mutant (quad; etmf mutant; see 
Experimental Procedures) defective in the expression of these four proteins for infection of J774.A1 
cells along with EPEC and T3SS-defective mutants (cfm-14 and sep-2). Pre-activated bacteria were 
used to infect macrophages for 1hr and the number of extracellular and total cell-associated bacteria 
was determined, using a differential fluorescent based assay (see Experimental Procedures) as 
previously described (Celli et al., 2001; Goosney et al., 1999), to determine the percentage of 
internalised bacteria. Figure 1 demonstrates that, similar to previous reports with J774.A1 or LMmev 
macrophages (Celli et al., 2001; Goosney et al., 1999), ~40% of cell-associated EPEC were 
internalised in contrast to ~70% for the T3SS-defective cfm-14 and sep-2 strains. Similar analysis of 
quad-infected cells revealed that this mutant was as defective as the T3SS mutants at inhibiting 
internalisation, indicating roles for one or more of the deleted gene products.  
 
Essential role for EspF in inhibiting the PI-3 kinase-dependent internalisation process 
To confirm the reported non-essential nature of the individual Tir, Map, EspF and Intimin proteins in 
inhibiting internalisation (Celli et al., 2001; Kenny and Jepson, 2000; Goosney et al., 1999), J774.A1 
macrophages were infected with tir, map, espF or eae (Intimin) single deletion mutants prior to 
determining the percentage internalised bacteria. Whilst this investigation confirmed the non-essential 
nature of Tir, Map and Intimin in inhibiting internalisation, EspF, in contrast to a previous publication 
(Celli et al., 2001), was found to be essential as the espF mutant failed to inhibit uptake in a manner 
indistinguishable from the T3SS mutant (Fig. 1).  
Studies with LMmev macrophages have shown that EPEC internalisation occurs by PI-3 
kinase-independent and -dependent processes, with only the latter inhibited by EPEC (Celli et al., 
2001). To determine whether this was the same case for J774.A1 macrophages, cells were left 
untreated or pre-treated with the PI-3 kinase specific inhibitor (LY294002), as previously described 
for LMmev macrophage (Celli et al., 2001), prior to infection with EPEC, espF, quad and cfm-14 
(T3SS-defective) strains. As with LMmev macrophage (Celli et al., 2001) the internalisation process 
responsible for uptake of ~40% of EPEC was independent of PI-3 kinase whilst pre-treatment with 
LY294002 reduced the number of internalised espF, quad and T3SS-defective bacteria to levels 
observed with wild type EPEC-infected cells (Fig. 2). Thus, EPEC specifically inhibits a PI-3 kinase-
dependent internalisation processes in J774.A1, as reported for LMmev, macrophages (Celli et al., 
2001).  
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EspF targeting mitochondria is not required to inhibit bacteria uptake  
To verify the dependence of this inhibitory process on EspF, the espF mutant was transformed with 
plasmids expressing EspF (native protein or T7-EspF fusion) for infection of J774.A1 cells. Indeed, 
plasmid expression of EspF (Fig. 3A and B), or T7-EspF (not shown), rescued the ability to inhibit the 
internalisation. Similar infections with the quad mutant carrying an EspF-expressing plasmid 
(encoding a T7-EspF fusion protein) revealed no roles for Map, Tir or Intimin in this EspF-mediated 
activity as this strain inhibited the uptake process to the same degree as wild type EPEC (Fig. 3C). 
Thus, EspF possesses an activity that functions independently of Map, Tir or Intimin to inhibit PI-3 
kinase-dependent uptake. 
The EPEC EspF and Map proteins are similarly sized molecules (206 and 203 residues, 
respectively) that target mitochondria and disrupt organelle membrane potential (Nagai et al., 2005; 
Nougayrede and Donnenberg, 2004; Kenny and Jepson, 2000). Both proteins have N-terminal 
mitochondrial targeting (MTS) sequences (Papatheodorou et al., In Press) with predicted 
mitochondrial import cleavage (MIC) signal sequences (http://psort.nibb.ac.jp/) at amino acid 101 and 
41 of EspF and Map, respectively. Importantly, EspF targeting to mitochondria is abolished by 
substituting leucine (L), at position 16, to glutamic acid (E) (Nagai et al., 2005). Thus, to investigate a 
role for mitochondrial targeting in inhibiting bacterial internalisation, J774.A1 macrophages were 
infected with espF carrying an EspF L16E expressing plasmid. Figure 3A and B reveals that this EspF 
molecule retains its ability to inhibit uptake while fluorescent microscopy studies confirmed the 
accumulation in this EspF protein within cytoplasm and not punctuate mitochondrial structures (data 
not shown), as previously reported (Nagai et al., 2005). Thus, EspF inhibits PI-3 kinase-dependent 
internalisation by a mechanism that does not require targeting to mitochondria.  
 
The EspF C-terminal domain encodes sufficient information to disrupt epithelial barrier function 
but not to prevent PI-3 kinase-dependent uptake  
Given that the EspF predicted MIC cleavage site is at residue 101 residues while the first 24 are 
sufficient for mitochondrial targeting (Nagai et al., 2005), this raised the possibility that the additional 
N-terminal residues possess signalling functions. We previously demonstrated that substitution of the 
putative MTS region of Map for the N-terminal 107 residues of Tir (serves to deliver the Map domain 
into host cells) abolished mitochondrial targeting without compromising Map’s ability to induce 
Cdc42-dependent filopodia formation or disruption of epithelial barrier function (Dean and Kenny, 
2004; Kenny et al., 2002). Thus, to test the role of the EspF N-terminal 101 residues this region was 
similarly replaced with the N-terminal 107AA of Tir (Tir-Δ101EspF fusion protein) for expression 
from the plasmid pΔ101espF (see Experimental Procedures). Figure 4A demonstrates that introduction 
of pΔ101espF into espF failed to rescue the ability to inhibit bacterial uptake.  
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Additional infections were carried out on differentiated Caco-2 cells to determine whether the 
fusion protein retained the EspF function that disrupts epithelial barrier function. As previously 
reported (Dean and Kenny, 2004; Kenny et al., 2002), the espF mutant is partially defective in 
disrupting barrier function (as monitored by changes in transepithelial electric resistance; TER) 
compared to wild type EPEC, with this defect rescued by plasmid expression of EspF (Fig, 4B). 
Importantly, plasmid expression of the Tir-Δ101EspF fusion protein rescued this espF defect revealing 
the functionality of the fusion protein in this regard and independence of this activity, unlike inhibition 
of bacterial uptake, on the N-terminal 101 residues.  
 
Inhibition of bacterial uptake is not correlated with loss of phosphorylation of the PI-3 kinase 
substrate, Akt, nor gross dephosphorylation of host phosphotyrosine proteins 
Loss of phosphorylation of the PI-3 kinase substrate, Akt, during the infection process has previously 
been correlated with inhibition of EPEC uptake (Celli et al., 2001). To examine the validity of this 
correlation J774.A1 cells were infected, as described for LMmev macrophages (see Experimental 
Procedures), with WT, espF, quad and cfm-14 strains for 15, 30, 60 and 90 minutes prior to isolating 
cellular extracts. Examining Akt phosphorylation revealed that as with LMmev macrophages (Celli et 
al., 2001), EPEC infection triggered the phosphorylation of Akt on Ser473 with this modification a 
transient event for wild type EPEC-infected cells while sustained for T3SS mutant-infected cells (Fig. 
5A top panels). The PI-3 kinase-dependent nature of modification was confirmed by pre-treatment of 
J774.A1 cells with the PI-3 kinase specific inhibitor LY294002 as thus abolished Akt phosphorylation 
in response to EPEC infection (Fig. 5B), as reported with LMmev macrophages (Celli et al., 2001). 
Surprisingly, the espF and quad mutants both triggered transient Akt Ser473 phosphorylation, like 
wild type EPEC, despite their inability to inhibit PI-3 kinase-dependent uptake. Thus, this not only 
uncouples these two events but also reveals that EPEC employs non-Tir, Map, EspF or Intimin-
mediated signalling to trigger the loss of PI-3 kinase-dependent phosphorylation of Akt.  
 To explore whether EspF is also responsible for triggering the gross dephosphorylation of host 
phosphotyrosine proteins - the phenotype that indicated EPEC’s capacity to inhibit phagocytosis (Celli 
et al., 2001; Goosney et al., 1999) - cellular extracts from cells infected with EPEC, espF and cfm-14 
(T3SS-defective) strains were probed with phosphotyrosine specific antibodies. While this confirmed 
the T3SS-dependent ability of EPEC to dephosphorylate a large number of macrophage 
phosphotyrosine proteins (Celli et al., 2001; Goosney et al., 1999) it discounted a major role for EspF 
in the process (Fig. 5C).  Thus, the ability of EPEC to inhibit PI-3 kinase uptake by macrophages 
could not be linked to loss of phosphorylation of the PI-3 kinase substrate, Akt, nor EPEC’s ability to 
dephosphorylate a large number of host phosphotyrosine proteins.  
 
Discussion 
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The delivery of the enteropathogenic E.coli (EPEC) EspF effector protein into host cells via the type 
three secretion system is associated with mitochondrial dysfunction, cell death and disruption of 
epithelial barrier function (Nagai et al., 2005; Dean and Kenny, 2004; Nougayrede and Donnenberg, 
2004). Here we show that, in contrast to another study (Celli et al., 2001), EspF is also an essential 
factor to enable EPEC to inhibit their uptake into macrophages by a PI-3 kinase-dependent pathway. 
This discrepancy from the previous study (Celli et al., 2001) is unlikely to stem from the use of 
different macrophage cell lines as J774.A1 were shown to respond to EPEC infection in an manner 
indistinguishable to that described with LMmev macrophages, except for espF dependence (Fig 1 -5), 
and indeed have previously been used interchangeably (Celli et al., 2001; Goosney et al., 1999). The 
nature of the espF mutant used in this study has been validated by i) exhibiting a similar defect in 
disrupting barrier function (Fig, 4A) (Dean and Kenny, 2004) as described with the original espF 
mutant (McNamara et al., 2001) ii) strains carrying independently generated espF-related deletions 
(ie.e espF and quad) both failing to inhibit the uptake process and iii) these espF/quad defects being 
rescued by introducing of EspF-expressing plasmids generated in this (T7-EspF) and another (EspF; 
EspF L16E) laboratory (Nagai et al., 2005; Dean and Kenny, 2004; Nougayrede and Donnenberg, 
2004). Whatever the nature of the difference, the described system provides a model to allow the 
nature of this EspF inhibitory activity to be defined as well as the opportunity to shed light on the 
cellular mechanisms regulating PI-3 kinase-dependent uptake process by professional phagocytes. 
 Importantly, EspF inhibition of PI-3 kinase uptake was shown to be independent of 
mitochondrial targeting (Fig. 3B) demonstrating its capacity to function outside these organelles and 
that this inhibition on uptake is not a direct or indirect consequence of EspF interfering with 
mitochondrial function. While EPEC infection of macrophages can induce cell lifting, as previously 
described with non-phagocytic cell lines (Shifrin et al., 2002), this process is not evident under the 
conditions used in this study (not shown). Moreover, a T3SS-competent strain defective in triggering 
cell lifting still inhibited the PI-3 kinase-dependent uptake process (Maresca and Kenny, unpublished) 
supporting the premise that EspF inhibits uptake by a specific mechanism.  
The predicted presence of a mitochondrial import cleavage (MIC) site at residue 101 in EspF, 
(http://psort.nibb.ac.jp/), despite the first 24 residues being sufficient to target proteins to mitochondria 
(Nagai et al., 2005; Dean and Kenny, 2004; Nougayrede and Donnenberg, 2004) indicated that the N-
terminal domain may encode additional functions. Indeed, this appears to be the case as substituting 
these 101 residues for the N-terminal 107 residues of Tir (serves to deliver the EspF C-terminal 
domain into host cells) negated the ability to inhibit PI-3 kinase dependent uptake into macrophages 
(Fig. 4A) but not disruption of epithelial barrier function (Fig. 4B). Thus, the N-terminus of EspF 
appears to play a crucial role in inhibiting the uptake process whilst the C-terminal (polyproline 
containing) domain is not sufficient. However, it is possible that the C-terminal domain may play a 
role in the inhibitory process but can not function when fused to the large Tir domain and/or requires 
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features of the N-terminal EspF domain. Interestingly, this EspF-mediated inhibition of PI-3 kinase-
dependent uptake is not dependent on bacteria co-expressing Map, Tir or Intimin (Fig. 3C), unlike 
EspF’s role in disrupting epithelial barrier function which requires co-expression of Intimin (Dean and 
Kenny, 2004). Nevertheless, it is possible that EspF require the co-expression/co-delivery of other, as 
yet unidentified, bacterial molecules to inhibit PI-3 kinase-dependent uptake.  
The recent finding that EspF can be found in a complex with the host intermediate filament 
component, cytokeratin 18 (CK18), and the adaptor protein 14-3-3 - the zeta isoform - (Viswanathan 
et al., 2004) raises a possible role for such interactions in inhibiting PI-3 kinase-dependent uptake. 
Intriguingly, 14-3-3 zeta can form a complex with PI-3 kinase during platelet activation and is 
postulated to function in the translocation of signalling proteins to the activated cytoskeleton (Munday 
et al., 2000). However, EspF is a multifunctional multidomain protein so such interactions may play 
roles in other subversive activities, especially as 14-3-3 zeta is implicated in regulating many cellular 
processes including proliferation, cell cycle, apoptosis and differentiation (Bialkowska et al., 2003). 
The identification of a translocation competent mutant defective in inhibiting the PI-3 kinase-
dependent uptake process was crucial for unlinking (Fig 5) this inhibitory process from previous 
correlations with loss of Akt phosphorylation, as a marker of PI-3 kinase inactivation (Celli et al., 
2001), and gross dephosphorylation of host phosphotyrosine proteins (Kenny and Finlay, 1997). It is 
possible that these two processes are in fact related given the importance of tyrosine phosphorylation-
mediated signalling in phagocytosis (Swanson and Hoppe, 2004; Stephens et al., 2002). However, this 
must await the identification of the responsible factors which we have shown function independent of 
Map, EspF, Tir or Intimin. Further studies are currently underway to examine the mechanism by 
which EspF inhibits the PI-3 kinase-dependent uptake process and to determine whether this occurs at 
the level of PI-3 function or at another point in the uptake process.  
 
Experimental Procedures 
Bacterial strains and cell lines 
The (WT) EPEC strain (E2348/69; O127:H6) and mutants used in this study are listed in Table 1. 
Bacteria were streaked from frozen culture stocks onto Luria-Bertani (LB) agar plates supplemented 
with nalidixic acid, carbenicillin, chloramphenicol or  kanamycin (50, 100, 25, and 25 μg/ml final 
conc, respectively) as required. The day prior to infection, LB broth supplemented with the 
appropriate antibiotic was inoculated from a single colony and incubated over night at 37°C without 
shaking.   
 
J774.A1 cell (ATCC TIB-67) and Caco-2 cells (ATCC No. HTB-37) were grown in Dulbecco’s 
minimal Eagles Medium (DMEM) supplemented with 10% (v/v) heat-inactivated fetal calf serum 
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(FCS), 2 mM L-glutamine, 1% non-essential amino-acids (all from Invitrogen) and 1% antibiotics 
(Penicillin/Streptomycin, 100 units/mL final concentration; Sigma).  
 
espF plasmids  
Plasmids encoding EspF and EspFL16E have previously been described (Nagai et al., 2005). To 
generate Δ101EspF the sequence encoding the C-terminal half of EspF (from amino acid 101) was 
PCR amplified using a pair of oligonucleotides (Invitrogen) designed to introduce a unique EcoR1 at 
the 5’end while exploting the presence of a unique EcoRV site ~60bp downstream of the espF stop 
codon. The resulting PCR fragment was digested EcoR1/EcoRV and used to replace the EcoR1/HincII 
fragment of pSK-tirΔMTSmap (Kenny et al., 2002) thus swapping the ΔMTSmap sequence for 
ΔMTSespF generating pΔ101espF. 
 
Generation of the etmf quadruple mutant 
Mutants carrying deletions of the individual LEE genes, intimin (eae), tir, espF and map, using allelic 
exchange and the suicide vector pCVD442 have previously been described (see Table 1). To generate 
a strain missing all four genes, the Intimin (eae) mutant was used as a recipient for pCVD442-Δtir, as 
previously described (Kenny et al., 1997), to generate the eaetir double mutant. In a similar manner, 
the eaetir double mutant was used as a recipient for pCVD442-Δmap generating the eaetirmap triple 
mutant. Finally, the eaetirmap triple mutant was used as a recipient for pCVD442-ΔespF generating 
the eaetirmapespF (etmf) quadruple mutant. The absence of expression and/or secretion of the protein 
product of targeted deleted genes was confirmed by Western blot analysis, whilst confirming normal 
secretion of the EPEC secreted proteins (Esp).   
  
Fluorescent microscopy determination of bacterial uptake   
Overnight bacterial cultures were diluted 1:50 in DMEM and incubated at 37oC in a 5% CO2 
atmosphere to induce LEE gene expression. Approximately 2.5 X 105 J774.A1 macrophages were 
seeded onto glass coverslips in 24 well plates and incubated in DMEM containing 10% fetal calf 
serum and Penicillin/Streptomycin for two days prior to infection. 30 min before infection the J774.A1 
cells were washed with PBS and bathed in DMEM containing only those antibiotics required to select 
bacterial strains in addition to the PI-3 kinase inhibitor (LY294002; 25μM final concentration) when 
required. Infections were 1 hr at a multiplicity of infection (MOI) of ~20 bacteria per macrophage, 
prior to washing trice with PBS and fixing cells for 30 min at room temperature with 2.5% 
paraformaldehyde. Washed cells were incubated with anti-0127 antibodies (kindly provided by Rob 
La Ragione, Veterinary Laboratories Agency, Addlestone, Surrey) for 30 min, washed trice with PBS 
and incubated for a further 30min with TRITC-conjugated goat anti-rabbit antibodies to label 
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extracellular EPEC. Total cell-associated EPEC were similarly detected except that anti-EPEC 
antibodies were incubated in the presence of 0.1% Saponin, to permeabilise the host cells, and labelled 
with FITC-conjugated goat anti-rabbit antibodies. J774.A1 cells with 20-40 cell-associated bacteria 
were identified using a Zeiss Axioskop Epifluorescent microscope and the number of extracellular and 
total cell-associated bacteria scored for 50 randomly selected cells per coverslip and the number of 
internalised bacteria calculated.  
 
Akt phosphorylation assay 
Approximately 1.2 x106 J774.A1 macrophages were seeded into 60 mm tissue culture dishes in the 
presence of DMEM containing 10% foetal calf serum, 2 mM L-glutamine and Penicillin/Streptomycin 
for 2 days prior to infection. The night preceding infection, the macrophages were serum starved by 
exchanging the media for DMEM containing 0.5% foetal calf serum. The cells were washed and the 
media replaced with DMEM 3h prior to infection. Overnight bacterial cultures were diluted 1:50 in 
fresh DMEM and incubated for 3h at 37oC in a 5%CO2 atmosphere to induce LEE gene expression. 
Macrophages were left uninfected (0) or infected for 15, 30, 60 or 90min at a MOI of 20:1 prior to 
washing the cells twice with cold PBS (4oC) and extracting total protein in 100μl protein sample 
loading buffer (Laemmli, 1970). Cells present in media or washes were retrieved by centrifugation 
(625 X g for 5 min) and added to extracts to ensure samples contained similar numbers of host cells. 
Samples were boiled 5 min and proteins separated by SDS-PAGE on 6% or 12% gels (Laemmli, 
1970), transferred to nitrocellulose and used for western blot analysis probing with mouse 
antiphosphotyrosine (4G10; Upstate), Akt or phosphoserine 473 Akt (Cell Signalling 9272 and 92715 
respectively) specific antibodies according to manufacture’s recommendations. Goat anti-mouse 
antibodies conjugated to alkaline phosphate were used to detect phosphotyrosine proteins using 
alkaline phosphatase detection kit (Promega S3771) while antibodies conjugated to horse radish 
peroxidase were used to detect Akt related proteins using the ECL Advance detection kit (Amersham 
RPN 2135). 
 
Monitoring Barrier function 
Caco-2 cell lines were routinely maintained on 75 cm2 flasks at 37°C in a humidified atmosphere of 
5% CO2. Cells were used between passages 20-40 and seeded onto 1cm2 Transwell-Clear inserts 
(Corning) at a density of 250,000 cells/cm2. Cells were grown for 10-12 days post-seeding to facilitate 
differentiation as reflected by increasing transepithelial electrical resistance (TER) as monitored with 
an EVOM voltohmeter (World Precision Instruments). For infection, the optical density (A600) of 
overnight bacterial cultures were measured and the bacteria diluted in DMEM to an A600 of ~0.03. 
Bacteria were grown in this medium (at 37oC in 5% CO2) for 3 h prior to being added to the apical 
surface of Caco-2 monolayers (~5 X 107 bacteria per well). Two hours prior to bacterial infection, the 
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Caco-2 monolayers were washed in pre-warmed DMEM, to allow the TER stabilisation, with changes 
in TER measured at 37oC over a 6hr infection period.  
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Table 1: List of EPEC strains used. 
 
Strain Description Reference 
E2348/69 WT EPEC strain, NalR (Levine et al., 1985) 
sep-2 (CVD452) Defective T3SS, NalR (Jarvis et al., 1995) 
cfm-14 Defective T3SS, KmR (Donnenberg et al., 1990) 
eae (CVD206) Intimin minus, NalR  (Donnenberg and Kaper, 1991) 
espF  EspF minus, NalR (Warawa et al., 1999) 
map  Map minus, NalR (Kenny and Jepson, 2000) 
tir  Tir minus, NalR (Kenny et al., 1997) 
quad (etmf) Map, EspF, Tir, Intimin minus This study 
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Figure Legends 
Figure 1 The EPEC EspF effector molecule plays an essential role in inhibiting EPEC internalisation 
into J774.A1 macrophages. J774.A1 macrophages were infected with pre-activated wildtype EPEC 
(WT), tir, eae (Intimin), map, espF, quad (Δmap, espF, tir, eae [Intimin]) and T3SS-defective (cfm-14 
and sep-2) strains for 1 hr prior to determining the percentage of internalised bacteria using differential 
fluorescent labelling of extracellular and total cell-associated bacteria (see Experimental Procedures). 
Data relates to at least three independent experiments with error bars indicating the standard deviation. 
 
Figure 2 EPEC T3SS-dependent inactivation of a PI-3 kinase-dependent internalisation process in 
J774.A1 macrophages. J774.A1 macrophages were incubated in the presence (plus) or absence 
(minus) of the PI-3 kinase specific inhibitor, LY294002, prior to infecting with pre-activated EPEC 
strains - wildtype (WT), espF, quad (Δmap, espF, tir, eae [Intimin]) and T3SS-defective (cfm-14) 
mutants. Differential fluorescent labelling of extracellular and total cell-associated bacteria was 
employed to determine the percentage of internalised bacteria (see Experimental Procedures). Data 
relates to at least three independent experiments with error bars displaying the standard deviation. 
 
Figure 3 EspF-mediated inhibition of PI-3 kinase-dependent uptake is independent of mitochondrial 
targeting or the activity of Map, Tir and Intimin. J774.A1 macrophages were infected 1 hr with pre-
activated wild type EPEC (WT), T3SS-defective (cfm-14), quad (Δmap, espF, tir, eae [Intimin]), espF 
or espF carrying plasmids encoding EspF (pespF), EspFL16E (pespFL16E; abolishes targeting to 
mitochondria) or T7-EspF (pΤ7−espF) fusion proteins. A) shows representative micrographs of 
infected cells using differential fluorescent labelling to identify extracellular as well as total cell-
associated bacteria to enable the percentage of internalised bacteria to be calculated (see Experimental 
Procedures). B) and C) show the results of quantification studies from at least three independent 
experiments with error bars displaying standard deviation. 
 
Figure 4 The C-terminal half of EspF rescues the ability to disrupt epithelial barrier function but not 
inhibition of PI-3 kinase-dependent uptake. J774.A1 macrophages were infected 1 hr with pre-
activated wild type EPEC (WT), T3SS-defective (cfm-14), espF or espF carrying a plasmid 
pΔ101espF (encodes a Tir-EspF fusion protein where the N-terminal 101 EspF residues are substituted 
for the corresponding 107 of Tir) prior to determining the percentage internalised bacteria by 
differential fluorescent labelling (see Experimental Procedures). Data shown is from at least 3 
independent experiments with error bars displaying the standard deviation. In B) Caco-2 cells, 
differentiated for 10 to 12 days on porous inserts, were left uninfected or infected with wild type 
EPEC (WT), T3SS-defective mutant (cfm-14), espF or espF carrying plasmids encoding T7-EspF 
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(pespF) or Tir-EspF (pΔ101espF) fusion proteins with disruption of epithelial barrier function 
monitored by following changes in transepithelial electrical resistance (TER). Data relates to at least 
three independent experiments with error bars displaying standard deviation. 
 
Figure 5 Inhibition of EPEC uptake into J774.A1 macrophages is not correlated with loss of 
phosphorylation of the PI-3 kinase substrate, Akt, nor gross changes in host phosphotyrosine protein 
profile. Serum starved J774.A1 macrophages were left uninfected (0) or infected with pre-activated 
EPEC strains in the presence (+) or absence (-) of the PI-3 kinase inhibitor LY294002 (LY).  Strains 
used were wildtype (WT), T3SS-defective (cfm-14), espF and quad (Δmap, espF, tir, eae [intimin]) 
with infections carried out for (A, C) 15, 30, 60 and 90 and (B) 90 min minutes prior to isolating total 
cell extracts for separated on (A, B) 12% or C) 6% SDS-PAGE prior to transferring to nitrocellulose 
and probing in for (A, B) total Akt (bottom panels) and the serine 473 phosphorylated form (top 
panels) and (C) tyrosine phosphorylated proteins. Arrow heads in C) indicate the position of the T3SS-
delivered tyrosine phosphorylated Tir molecule, with the band below this presumably corresponding 
to the bacterial cell-associated tyrosine phosphorylated protein, Ep85 (Rosenshine et al., 1992). Data 
shown is representative of that obtained from at least three independent experiments. 
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